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Abstract 
BACKGROUND: Kaposi's sarcoma (KS) is a tumour of endothelial, blood and lymphatic cells, caused by an 
infection with human herpesvirus-8 (HHV-8). The skin lesions of KS, especially of the classical or Mediterranean 
variant (CKS), are represented by red-purple macules, plaques and nodules, localised mainly on the extremities.  
CASE REPORT: This case series intend to describe multifocal atypical kaposian manifestations in two HIV 
negative subjects, affected by CKS, treated with successful chemotherapy. 
CONCLUSIONS: Although atypical manifestations are extremely rare events, we suggest an accurate, objective 
examination because a prompt diagnosis can lead to a vital intervention in the patient's health and sometimes to 
the identification of the disease itself. 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
 
Kaposi sarcoma (KS) is a malignant 
neoplasm with multifocal diffusion, originating from 
endothelial cells, associated with human herpesvirus-
8 (HHV-8). HHV‐8 infection remains latent, and most 
people do not develop KS until their immune system is 
affected by the disease, such as human 
immunodeficiency virus (HIV), or by drugs are given 
after an organ transplant [1].
 
According to the literature, there is still no 
standard treatment of CKS. The prognosis and choice 
of treatment depend on the type of KS, the global 
assessment of the patient, in particular, the patient's 
immune system, whether cancer has just been 
diagnosed or has recurred [2].
 
Herein we present two cases of an HIV-
negative Mediterranean male with disseminated skin 
KS treated with different therapy, obtaining a 
remission of clinical manifestations. 
 
 
Case 1 
 
A 78-year-old Italian man attended our 
attention in January 2018 for a 2-years history of red 
lesions on his lower legs, treated incorrectly for 
chronic stasis dermatitis. His medical history was 
relevant for compensated type 2 diabetes mellitus and 
hypertension. Clinical examination showed multiple 
blue and purplish red nodules varying in size from 1-3 
cm, affecting the lower legs and forefoot, abdomen, 
neck, oral mucosa, tongue and genital region (Figure 
1). A sample of the skin biopsy showed proliferation of 
fusiform cells and endothelial cells with extravasation 
of red blood cells and intervening slit-like spaces. 
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Endothelial cells were positive HHV-8 by 
immunohistochemistry. 
 
Figure 1: Multiple blue and purplish red nodules varying in size from 
1-3 cm affecting the neck 
 
These findings were consistent with Kaposi 
Sarcoma diagnosis, nodular stage. Laboratory 
investigations showed HIV test negativity (antibodies 
anti HIV1/2-antigen p24), White Blood Cells 10.57 x 
10
3
/uL (normal range 4.8-10.8), Red Blood Cells 4.16 
x 10
6
/uL (4.2-5.6), Platelets 234 x 10
3
/uL (130-400); 
Hb 15 g/dL (12-17.5), liver function [ALT 21 U/L (0 – 
55); AST 22 U/L (0 – 34)] and renal function 
[creatinine 0.7 mg/dL (0.7-1.2)] tests within the normal 
limit. Chest X-ray, abdominal and lymph node 
ultrasound and low gastrointestinal endoscopy were 
normal. Faecal occult blood test and video-
laryngoscopy were performed, and no abnormalities 
were documented. Considering widespread skin 
involvement (> 25 lesions) and oral lesions, he was 
put on monthly chemotherapy with vinblastine dose of 
10 mg. White blood count was normal, and patient-
reported only nausea. The clinical examination nine 
months after starting therapy showed clinical 
improvement with reduction of nodules dimension 
(Figure 2). After one year, no recurrence was 
observed. 
 
Figure 2: Clinical improvement with reduction/absence of nodules 
dimension 
 
 
Case 2 
 
An 82-year-old Italian man HCV-positive 
(HCV antibodies positive) and HIV negative 
(antibodies anti-HIV1/2-antigen p24), with a 5-year 
history of KS, presented to our attention in March 
2015. Clinical examination showed a red-brownish 
nodular lesion on the left nostril, about 1 cm in 
diameter, without systemic symptoms. Excisional 
biopsy and histological examination were performed 
with confirmation of KS’diagnosis: the lesion presents 
angiomatous areas surrounded by spindle cells (HHV-
8 positive by immunohistochemistry), perivascular 
inflammatory infiltrate with T and B cells. Almost 
simultaneously, nodular lesions confluent into plaques 
in the lower limbs appeared, for which cycles of 
chemotherapy with vinblastine (10 mg) began one 
time a month, with improvement of manifestations 
without side effects (white blood cells [7.87 x 10
3
/uL 
(4.8-10.8)], transaminases [ALT 11 U/L (0 – 55); AST 
18 U/L (0 – 34)]).  
In August 2017, chemotherapy was 
discontinued due to an acute myocardial infarction. In 
November of the same year, for the improvement of 
the cardiac clinical conditions and previous 
oncological counselling, therapy with vinblastine 
resumed under strict cardiological control. After 7 
months, the patient reported the appearance of two 
adjacent intraorbital nodules, the medial area of the 
left tear chamber, of a brownish red colour from the 
diameter of about 5 mm, indicative of kaposian lesions 
(Figure 3). 
Being the lesion particularly proliferative and 
not responsive to vinblastine, we proceeded with the 
removal of the same to restore the visual features and 
avoid the further increase. 
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Figure 3: Two adjacent intraorbital nodules, the medial area of the 
left tear chamber, of a brownish red colour from the diameter of 
about 5 mm 
 
The operation, performed at the eye clinic 
(May 2018), and the subsequent histological 
examination confirmed KS. Currently, the patient 
practices cycles of liposomal doxorubicin, finding a 
containment of the manifestations. After six months, 
there are no other ocular manifestations (Figure 4). 
 
Figure 4: Complete resolution after surgical treatment 
 
 
Discussion 
 
KS is an angioproliferating skin cancer can 
involving mucosa and viscera, like a respiratory and 
gastrointestinal system [3].  
KS is one of the most common sarcomas in 
patients with AIDS, but in its classical form (CKS) it is 
found widespread especially in the Mediterranean 
area [4]. The epidemiology of KS partially reflects the 
seroprevalence of HHV-8 infection. HHV-8 infection 
has a low incidence, less than 5%, in Asia, Northern 
Europe, Australia and America, while it increases in 
Mediterranean countries (with diffusion in southern 
Italy) and in Africa sub-Saharan, with the preferential 
non-sexual transmission as determined by the high 
incidence of seropositive children [5]. The CKS 
prevails in the Mediterranean basin. In America, the 
percentage is higher in AIDS patients. The highly 
active antiretroviral therapy in the treatment of HIV 
disease showed a reduction of AIDS-associated 
sarcoma Kaposi [6]. 
Head and neck involvement in HIV-negative 
patients is uncommon, reported in less than 5% of 
classical forms. Classical skin lesions generally 
consist of angioedematous plaques and nodules 
located on the limbs, on the contrary, HIV-related form 
is characterised by disseminated cutaneous 
manifestations, with oral and craniofacial involvement 
in about 95% of patients [7], [8]. However, in our 
cases, chemotherapy with vinblastine seems to be 
effective, with control of atypical manifestations 
without evidence of skin recurrence or visceral 
involvement. Ocular involvement, although atypical, is 
more frequent in the HIV-related form where it may 
even represent the first clinical sign [9]. Our 
experience proves the importance of accurately 
identifying the ocular involvement of Kaposi's 
sarcoma, which can be confused with simple 
angiomatous lesions. Although it is an extremely rare 
event, a prompt diagnosis can lead to a vital 
intervention in the patient's health and sometimes to 
the identification of the disease itself. Our cases show 
that the cutaneous manifestations of CKS do not 
always follow the trend of the Mediterranean variant, 
can take the typical manifestations of an HIV sarcoma 
preserving responsiveness to the therapy with 
vinblastine. 
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